FDA 21 CFR Part 200 to 299 Guidelines for Drugs

Sathyanarayana M.Sc.


Click on the titles below for complete guidelines

21 CFR Part 200 General

21 CFR Part 201 Labeling

21 CFR Part 202 Prescription Drug Advertising

21 CFR Part 203 Prescription Drug Marketing

21 CFR Part 205 Guidelines For State Licensing Of Wholesale Prescription Drug Distributors

21 CFR Part 206 Imprinting Of Solid Oral Dosage Form Drug Products For Human Use

21 CFR Part 207 Requirements For Foreign And Domestic Establishment Registration And Listing For Human Drugs, Including Drugs That Are Regulated Under A Biologics License Application, And Animal Drugs, And The National Drug Code

21 CFR Part 208 Medication Guides For Prescription Drug Products

21 CFR Part 209 Requirement For Authorized Dispensers And Pharmacies To Distribute A Side Effects Statement

21 CFR Part 210 Current Good Manufacturing Practice In Manufacturing, Processing, Packing, Or Holding Of Drugs; General

21 CFR Part 211 Current Good Manufacturing Practice For Finished Pharmaceuticals

21 CFR Part 212 Current Good Manufacturing Practice For Positron Emission Tomography Drugs

21 CFR Part 216 Human Drug Compounding

21 CFR Part 225 Current Good Manufacturing Practice For Medicated Feeds

21 CFR Part 226 Current Good Manufacturing Practice For Type A Medicated Articles

21 CFR Part 250 Special Requirements For Specific Human Drugs

21 CFR Part 251 Section 804 Importation Program

21 CFR Part 290 Controlled Drugs

21 CFR Part 299 Drugs; Official Names And Established Names

FDA 21 CFR Part 200 to 299 Guidelines for Drugs:

Post a Comment


Post a Comment (0)